Indications and uses
temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises cramps
temporarily relieves minor pain associated with: arthritis simple backache muscle strains sprains bruises cramps
adults and children over 18 years : squeeze desired amount of Capzasin Quick Relief Gel onto affected area using the sponge-top applicator, massage dispensed gel into painful area until thoroughly absorbed repeat as necessary, but no more than 3 to 4 times daily IF MEDICINE COMES IN CONTACT WITH HANDS, WASH WITH SOAP AND WATER children 18 years or younger: ask a doctor
Capzasin Quick Relief Gel
Capsaicin 0.025%
Topical analgesic
Menthol 10%
Topical analgesic
temporarily relieves minor pain associated with:
For external use only
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
adults and children over 18 years:
children 18 years or younger: ask a doctor
acrylates/C10-30 alkyl acrylate crosspolymer, allantoin, aloe barbadensis leaf juice, DMDM hydantoin, fragrance, glycerin, methylparaben, phenoxyethanol, propylene glycol, propylparaben, SD alcohol 40-2 (15%), steareth-2, steareth-21, triethanolamine, water (245-285)
KEEP CARTON AS IT CONTAINS IMPORTANT INFORMATION.
Distributed by: Chattem, Inc.
P.O. Box 2219
Chattanooga, TN 37409-0219
0049618-03
U.S.A. ©2010
www.chattem.com
Recyclable Carton
ARTHRITIS PAIN RELIEF
CAPZASIN TM
QUICK RELIEF GEL
NO-MESS
Sponge Applicator
PURIFIED
P
CAPSAICIN®
Topical Analgesic Gel
*SOURCE: 2009 Pharmacy Today Survey
Net wt 1.5 oz (42.5 g)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 855923 | capsaicin 0.025 % / menthol 10 % Topical Gel | PSN | 7 |
| 1043539 | CAPZASIN Quick Relief 0.025 % / 10 % Topical Gel | PSN | 7 |
| 1043539 | capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief] | SBD | 7 |
| 855923 | capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel | SCD | 7 |
| 855923 | capsaicin 0.025 % / menthol 10 % Topical Gel | SY | 7 |
| 1043539 | Capzasin Quick Relief (capsaicin 0.025 % / menthol 10 % ) Topical Gel | SY | 7 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 473d070d-1c38-488e-b991-c4d1bf45aab8 | Product name | 1 | 20210201 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-7516-0 | Capzasin Quick Relief | 42.5 g in 1 TUBE, WITH APPLICATOR | GEL | 42.5 | 7 | |
| 41167-7516-0 | Capzasin Quick Relief | 1 in 1 CARTON | GEL | 1 | 7 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAPSAICIN | ACTIVE INGREDIENT | S07O44R1ZM | 2 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 2 | |
| CAPSAICIN | ACTIVE MOIETY | S07O44R1ZM | 2 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 2 | |
| ALLANTOIN | INACTIVE INGREDIENT | 344S277G0Z | 2 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 2 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 2 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-7516 | 41167-7516-0 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAPSAICIN | S07O44R1ZM | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| ALLANTOIN | 344S277G0Z | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| TROLAMINE | 9O3K93S3TK | IACT |
| WATER | 059QF0KO0R | IACT |
| CARBOMER INTERPOLYMER TYPE A (55000 CPS) | 59TL3WG5CO | IACT |
| STEARETH-2 | V56DFE46J5 | IACT |
| STEARETH-21 | 53J3F32P58 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2023-10-25 | full-release | 2026-05-31 23:57:54 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / TOPICAL | 4 mg | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / TOPICAL | 4 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| ALLANTOIN | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Capzasin Quick Relief | CAPSAICIN AND MENTHOL | Chattem, Inc. | d6c313a3-8dc6-4231-95b6-ac9399e1c1be | 2026-01-13 | Warnings | 41167-7516-0 41167-7516 41167751600 c59167cb-f484-44bd-82b0-766e3f46ed50 d6c313a3-8dc6-4231-95b6-ac9399e1c1be |
Adverse event summaries are temporarily unavailable. Other product information remains available.